Adropin as a Novel Biomarker in the Diagnosis of Acute Pulmonary Embolism: a Prospective Analysis.
BACKGROUND Pulmonary embolism (PE) is a potentially life-threatening condition requiring rapid diagnosis and management. While computed tomography pulmonary angiography (CTPA) is the gold standard for diagnosis, its overuse raises concerns about radiation exposure and healthcare costs. The objective of this study was t...